CRS3123 is a potent, orally active, narrow-spectrum antibiotic that inhibits bacterial methionyl-tRNA synthetase; it exhibits potent activity against Clostridioides difficile and aerobic Gram-positive bacteria, with minimal activity against Gram-negative bacteria (including anaerobes); it has potential for the treatment of Clostridioides difficile infections.